Because patients with advanced CKD show hyperparathyroidism as well as elevated levels of blood phosphate and low 1,25-vitamin D, the concept of PTH hyporesponsiveness has been long considered to be a component of CKD-MBD (55). This evidence concerns the gene PTH and Marchiafava-Bignami disease.